FIRST FINANCIAL NORTHWEST INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of First Financial Northwest, Inc. - FFNW

Stock Information for Harpoon Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Harpoon Therapeutics Inc.

First Financial Northwest, Inc. Announces First Quarter 2024 Results; Reports Withdrawal from Legacy Defined Benefit Plan and Purchase of Single Premium Group Annuity
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FFNW, MGRC, CTLT, HRT
First Financial Northwest, Inc. Declares Quarterly Cash Dividend of $0.13 per Share
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates FFNW, TCN, JBT, NS
INVESTIGATION ALERT: Halper Sadeh LLC Investigates HARP, TARO, FFNW
CORRECTING and REPLACING - First Financial Northwest, Inc. Reports Net Income of $1.2 Million or $0.13 per Diluted Share for the Fourth Quarter and $6.3 Million or $0.69 per Diluted Share for the Year Ended December 31, 2023
First Financial Northwest, Inc. Reports Net Income of $1.2 Million or $0.13 per Diluted Share for the Fourth Quarter and $6.3 Million or $0.69 per Diluted Share for the Year Ended December 31, 2023
FFNW Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of First Financial Northwest Bank Is Fair to Shareholders

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.